UK markets closed

Tian'an Pharmaceutical Co., Ltd. (TNPH)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00660.0000 (0.00%)
At close: 02:47PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 979.64k
Enterprise value 979.64k
Trailing P/E 5.64
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.63
Price/book (mrq)1.20
Enterprise value/revenue 0.09
Enterprise value/EBITDA 0.23

Trading information

Stock price history

Beta (5Y monthly) -0.93
52-week change 3-73.49%
S&P500 52-week change 322.38%
52-week high 30.0249
52-week low 30.0028
50-day moving average 30.0066
200-day moving average 30.0081

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 62.62B
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2007
Most-recent quarter (mrq)31 Dec 2007

Profitability

Profit margin 29.51%
Operating margin (ttm)27.42%

Management effectiveness

Return on assets (ttm)18.01%
Return on equity (ttm)25.12%

Income statement

Revenue (ttm)10.65M
Revenue per share (ttm)0.76
Quarterly revenue growth (yoy)73.10%
Gross profit (ttm)N/A
EBITDA 4.31M
Net income avi to common (ttm)3.14M
Diluted EPS (ttm)0.0000
Quarterly earnings growth (yoy)71.20%

Balance sheet

Total cash (mrq)8.23M
Total cash per share (mrq)0.59
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)14.23
Book value per share (mrq)1.03

Cash flow statement

Operating cash flow (ttm)2.56M
Levered free cash flow (ttm)2.34M